A Comparison of Patient and Physician-rated New York Heart Association Class in a Community-based Heart Failure Clinic
Overview
Affiliations
Objective: The New York Heart Association (NYHA) classification is recommended for grading symptoms of chronic heart failure and is a powerful prognostic marker. Patient-rated NYHA (Pa-NYHA) and physician-rated NYHA (Dr-NYHA) class have never been compared directly, and it is unknown whether they carry similar prognostic significance.
Methods And Results: NYHA class was rated independently by a physician and patient in 1752 patients referred with suspected heart failure. Pa-NYHA and Dr-NYHA varied by 1 class in 37.1% cases and by 2 classes in 12.8% cases. Mean Dr-NYHA and Pa-NYHA were higher in women than men (1.98 vs 1.89, P = .016; 2.17 vs 2.02, P = .002) despite less cardiac disease. Dr-NYHA correlated more with 6-minute walk test distance and severity of left ventricular systolic dysfunction than Pa-NYHA (Spearman's rho: -0.53 vs -0.44 and 0.32 vs 0.16). Dr-NYHA better predicted mortality when compared with Pa-NYHA (log-rank: chi(2) = 105 vs 46, both P < .001).
Conclusion: Patients rate NYHA differently from physicians, and women rate NYHA differently from men. Dr-NYHA relates more strongly to survival and severity of left ventricular systolic dysfunction, suggesting that for physicians the NYHA classification may have become a "heart failure severity score" and not as was intended, purely a measure of a patient's symptoms and functional status.
Adejumo P, Thangaraj P, Dhingra L, Aminorroaya A, Zhou X, Brandt C JAMA Netw Open. 2024; 7(11):e2443925.
PMID: 39509128 PMC: 11544492. DOI: 10.1001/jamanetworkopen.2024.43925.
Siegersma K, Stens N, Groepenhoff F, Appelman Y, Tulevski I, Hofstra L Rev Cardiovasc Med. 2024; 23(8):278.
PMID: 39076639 PMC: 11266952. DOI: 10.31083/j.rcm2308278.
Adejumo P, Thangaraj P, Dhingra L, Aminorroaya A, Zhou X, Brandt C medRxiv. 2024; .
PMID: 38633789 PMC: 11023654. DOI: 10.1101/2024.03.30.24305095.
Arabadjian M, Montgomery S, Pleasure M, Nicolas B, Collins M, Reuter M Am Heart J Plus. 2024; 39:100367.
PMID: 38510995 PMC: 10945972. DOI: 10.1016/j.ahjo.2024.100367.
Prognostic Role of Metabolic Exercise Testing in Heart Failure.
Agdamag A, Van Iterson E, Tang W, Finet J J Clin Med. 2023; 12(13).
PMID: 37445473 PMC: 10342748. DOI: 10.3390/jcm12134438.